TP53 and neoplasm: Although we are not yet able to correlate the observed tumor cell–autonomous changes in the transcription of immune and inflammation-related genes with the observed tumor suppression and immune component activation in the syngeneic model, our data suggest that both intrinsic and nontumor cell–autonomous factors contribute to tumor suppression following p53 reactivation.